| ABBOTT INDIA  | 
The Current P/E Ratio of ABBOTT INDIA  is 42.34.
                
| Share Price | ₹29,003.2 | Oct 31,2025 | 
| Market Cap | ₹61,486.8 Cr | |
| Earnings-TTM | ₹1,452.3 Cr | TTM-Standalone Results | 
| Price/Earnings | 42.34x | Calculated as Market Cap/Earnings | 
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of ABBOTT INDIA
                    P/E = 
                    Market Capitalization 
                    / Net Income 
                    
                    or, using per-share numbers:
                    
                    P/E = Stock Price / 
                    Earnings Per Share (EPS)
                
               
                                     Current Market Cap [ ₹61,486.8 Cr] as on Oct 31,2025                     
                    (/) Earnings [ ₹1,452.3 Cr] based on TTM-Standalone Results
                                    
                
                (=) P/E Ratio [ 42.34x ]
            
Thus, for ABBOTT INDIA , the investors are currently willing to pay 42.34 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ABBOTT INDIA !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of ABBOTT INDIA over the last five years.
Historical PE (Price/Earnings) ratio chart of ABBOTT INDIA
PE Ratio Performance Analysis for ABBOTT INDIA
- ABBOTT INDIA 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 47.29x.
- ABBOTT INDIA 's operated at median p/e ratio of 47.09x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ABBOTT INDIA 's p/e ratio peaked in Mar2023 at 49.43x.
- ABBOTT INDIA 's p/e ratio hit its five-year low in Mar2021 of 46.11x.
How does ABBOTT INDIA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap | 
|---|---|---|---|
| ABBOTT INDIA | 1,452.29 | 42.34 | 61,486.8 | 
| SUN PHARMACEUTICAL INDUSTRIES LTD | 10,411.50 | 38.94 | 405,452.0 | 
| DIVIS LABORATORIES LTD | 2,306.00 | 77.66 | 179,089.0 | 
| CIPLA LTD | 5,453.86 | 22.24 | 121,299.0 | 
| TORRENT PHARMACEUTICALS LTD | 2,002.00 | 60.17 | 120,456.0 | 
| DR REDDYS LABORATORIES LTD | 5,721.40 | 17.47 | 99,965.9 | 
| MANKIND PHARMA LTD | 1,905.51 | 51.60 | 98,333.5 | 
| ZYDUS LIFESCIENCES LTD | 4,637.80 | 21.14 | 98,057.5 | 
| LUPIN LTD | 3,722.18 | 24.10 | 89,722.4 | 
| AUROBINDO PHARMA LTD | 3,417.93 | 19.35 | 66,133.0 | 
| ALKEM LABORATORIES LTD | 2,334.08 | 28.21 | 65,844.5 | 
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ABBOTT INDIA 's P/E Ratio
| Top 10 Industry Peers | PE Ratio | 
|---|---|
| Min industry PE | 17.47x | 
| Max industry PE | 77.66x | 
| Median industry PE | 28.21x | 
| Average industry PE | 36.66x | 
You may also like the below Video Courses
 
                                     
                                     
                                    